Cadila buys 50% stake of Zydus BSV from Bharat Serums

Cadila Healthcare Ltd, a Rs.7,200 crore pharma major from Ahmedabad, has purchased 50 per cent shares of Zydus BSV Pharma Pvt Ltd (Zydus BSV) from Bharat Serums and Vaccines Ltd (BSV) and now Zydus BSV has become 100 per cent subsidiary of Cadila Healthcare.







BSV is engaged in research, manufacturing and marketing injectable biological, pharma and biotech products. Its product portfolio comprises 25 brands which include plasma derivatives, monoclonals, fertility hormones, antifungals, anaesthetics, cardiovascular drugs and equine immunoglobulins/antitoxins.